G01 Glupamid: a novel nutraceutical approach to canine and feline osteoarthritis.

The article focuses on a study that analyzes the aliamide effect of Giupamid, an amide compound, in the well-established in vitro model of mast cell degranulation. The study showed that Glupamid is very active in reducing serotonin release in a concentration-dependent fashion. This characteristic of Glupamid demonstrates that the compound is active as an aliamide and strengthens its potential therapeutic use as a disease-oriented approach to osteoarthritis.